RayzeBio, Inc. reported that effective February 26, 2024, each of Richard Heyman, PhD, Tim Van Hauwermeiren, Maha Katabi, PhD, Yi Larson, Christy Oliger, Ken Song, MD, Mary Tagliaferri, MD, and Angie You, PhD resigned as a director of the Company and from all committees of the board of directors of the Company. Pursuant to the terms of the Merger Agreement, at the Effective Time, the directors of Purchaser as of immediately prior to the Effective Time, which consisted of Konstantina Katcheves, Sandra Ramos-Alves and Kimberly M. Jablonski, became the directors of the Company. Concurrently with such executive officers' removal, Benjamin Hickey was appointed to serve as President of the Company, Sandra Ramos-Alves was appointed to serve as a Vice President and Treasurer of the Company, Sophia Park was appointed to serve as a Vice President of the Company, Scott Matarese was appointed to serve as a Vice President of the Company, and Kimberly M. Jablonski was appointed to serve as a Vice President and Secretary of the Company.